바로가기메뉴

본문 바로가기 주메뉴 바로가기

ACOMS+ 및 학술지 리포지터리 설명회

  • 한국과학기술정보연구원(KISTI) 서울분원 대회의실(별관 3층)
  • 2024년 07월 03일(수) 13:30
 

Gemcitabine에 의한 약물 유발성 간질성 폐렴 1예

A Case of Drug Induced Interstitial Pneumonitis by Gemcitabine

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2004, v.56 no.3, pp.315-320
이성순 (인제대학교)
이혜란 (인제대학교)
최수전 (인제대학교)
이혁표 (인제대학교)
염호기 (인제대학교)
김수영 (인제대학교)
함초롬 (인제대학교)
진재용 (인제대학교)
김미영 (인제대학교)
이현경 (인제대학교)
  • 다운로드 수
  • 조회수

Abstract

Gemcitabine is an effective newly developed chemotherapeutic agent, which is increasingly being used to treat non-small cell lung, ovarian and breast cancers. Pulmonary toxicity is usually self-limiting mild dyspnea, bronchospasm, but severe pulmonary toxicity is rarely reported. Herein, we report drug induced interstitial lung disease associated with gemcitabine treatment. High resolution computerized tomogram (HRCT) showed an increased ground glass opacity and thickened septal lines. The patient showed a rapid good response with prednisolone treatment.(Tuberculosis and Respiratory Diseases 2004, 56:315-320)

keywords
Gemcitabine, Pulmonary infiltrates, Corticosteroid therapy, Gemcitabine, Pulmonary infiltrates, Corticosteroid therapy

참고문헌

1.

(1994) Gemcitabine:current status of phase I and II trials,

2.

(1994) Single agent activity of weekly gemcitabine in advanced non- small cell lung cancer:a phase II study,

3.

(1995) Advanced breast cancer: a phase II trial with gemcitabine,

4.

(1995) Dyspnoea with gemcitabine is commonly seen, often disease related, transient and rarely severe,

5.

(1997) Fatal pulmonary toxicity resulting from treatment with gemcitabine,

6.

(1998) Successful treatment of gemcitabine toxicity with a brief course of oral corticosteroid therapy,

7.

(1998) Diffuse alveolar damage in a patient treated with gemcitabine,

8.

(2002) Severe pulmonary toxicity in a patient treated with gemcitabine,

9.

(2000) Gemcitabine pulmonary toxicity : CT features,

10.

(1990) Fatal pulmonary failure complicating high-dose cytosine arabiꠀnoside therapy in acute leukemia,

11.

(1985) Subacute pulmonary failure complicating therapy with high dose ara-C in acute leukemia,

12.

(1997) Drugs that may injure the respiratory system,

13.

(1981) Ara-C Lung: noncardiogenic pulmonary edema complicating cytosine arabinoside therapy of leukemia,

Tuberculosis & Respiratory Diseases